Berjian R A, Parthasarathy K L, Didolkar M S, Bakshi S P, Moore R H
J Surg Oncol. 1980;13(1):53-60. doi: 10.1002/jso.2930130109.
To evaluate the clinical significance of 99mTc-sulfur-colloid (TsSC) spleen scan findings in patients with malignant melanoma, a retrospective study was undertaken. Eighty-one patients with histologically proven malignant melanoma who received treatment in Roswell Park during a five-year period were included in this study. The scans were analyzed for spleen size, differential uptake of the tracer in liver and spleen, and for the presence of metastases in these two organs. These data were compared with stage of disease, survival, and autopsy findings. Significant correlation was found between the splenic size as measured on the scintiscan and at autopsy examination. The spleen size was found to be normal in 92% of the patients in early melanoma. The median survival of patients who had a normal-sized spleen by scan criteria was found to be longer than those who had splenomegaly. No significant difference in survival was noted between the patients with and without augmented splenic uptake of TcSC. Only a small number (17.7%) of patients with augmented splenic uptake had splenic metastases; hence, the possible role of immunological factors was considered.
为评估99m锝-硫胶体(TcSC)脾脏扫描结果在恶性黑色素瘤患者中的临床意义,进行了一项回顾性研究。本研究纳入了81例在五年期间于罗斯韦尔公园接受治疗、经组织学证实为恶性黑色素瘤的患者。对扫描结果分析了脾脏大小、示踪剂在肝脏和脾脏中的摄取差异以及这两个器官中转移灶的存在情况。将这些数据与疾病分期、生存率和尸检结果进行比较。发现闪烁扫描测量的脾脏大小与尸检检查结果之间存在显著相关性。发现在早期黑色素瘤患者中,92%的患者脾脏大小正常。经扫描标准判断脾脏大小正常的患者的中位生存期长于脾肿大患者。脾脏摄取TcSC增加和未增加的患者之间在生存率方面未发现显著差异。脾脏摄取增加的患者中只有少数(17.7%)有脾脏转移;因此,考虑了免疫因素的可能作用。